CUTR vs. ELMD, FONR, VANI, HYPR, IRIX, POCI, ECOR, PXDT, MOVE, and BSGM
Should you be buying Cutera stock or one of its competitors? The main competitors of Cutera include Electromed (ELMD), FONAR (FONR), Vivani Medical (VANI), Hyperfine (HYPR), IRIDEX (IRIX), Precision Optics (POCI), electroCore (ECOR), Pixie Dust Technologies (PXDT), Movano (MOVE), and BioSig Technologies (BSGM). These companies are all part of the "electromedical equipment" industry.
Cutera (NASDAQ:CUTR) and Electromed (NYSE:ELMD) are both small-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, community ranking, profitability, analyst recommendations, media sentiment, earnings and institutional ownership.
90.7% of Cutera shares are held by institutional investors. Comparatively, 40.8% of Electromed shares are held by institutional investors. 2.1% of Cutera shares are held by insiders. Comparatively, 12.7% of Electromed shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Cutera has a beta of 1.43, suggesting that its stock price is 43% more volatile than the S&P 500. Comparatively, Electromed has a beta of 0.4, suggesting that its stock price is 60% less volatile than the S&P 500.
In the previous week, Cutera had 2 more articles in the media than Electromed. MarketBeat recorded 2 mentions for Cutera and 0 mentions for Electromed. Cutera's average media sentiment score of 0.90 beat Electromed's score of 0.00 indicating that Cutera is being referred to more favorably in the media.
Electromed has a net margin of 8.14% compared to Cutera's net margin of -73.42%. Electromed's return on equity of 10.97% beat Cutera's return on equity.
Electromed has lower revenue, but higher earnings than Cutera. Cutera is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.
Cutera presently has a consensus target price of $12.67, indicating a potential upside of 489.15%. Given Cutera's higher possible upside, equities research analysts plainly believe Cutera is more favorable than Electromed.
Cutera received 321 more outperform votes than Electromed when rated by MarketBeat users. However, 86.67% of users gave Electromed an outperform vote while only 64.85% of users gave Cutera an outperform vote.
Summary
Electromed beats Cutera on 9 of the 17 factors compared between the two stocks.
Get Cutera News Delivered to You Automatically
Sign up to receive the latest news and ratings for CUTR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CUTR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
